AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Previously Untreated, Older Adult Patients Unfit for Chemotherapy

Tareq Abuasab, Yesid Alvarado, Ghayas Issa, Rabiul Islam, Nicholas James, Musa Yilmaz, Nitin Jain, Lucia Masarova, Steven Kornblau, Elias Jabbour, Naveen Pemmaraju, Guillermo Montalban Bravo, Sherry Pierce, Courtney DiNardo, Tapan Kadia, Naval Daver, Marina Konopleva, Guillermo Garcia-Manero, Farhad Ravandi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Previously Untreated, Older Adult Patients Unfit for Chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences